Edgar Tracker

LFCR LIFECORE BIOMEDICAL, INC. \DE\

Nasdaq · CIK 1005286 · Pharmaceutical Preparations

SEC company page

Public articles

No public articles yet. Follow LFCR to track filings and write notes.

Recent filings

–

Form Filed Title Accession
8-K2026-10-208.01 Other Events0001005286-26-000040
SCHEDULE 13D/A2026-09-29—0001104659-26-111939
8-K2026-09-291.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits0001005286-26-000036
SCHEDULE 13D/A2026-09-28—0000921895-26-002661
DEFA14A2026-09-28DEFA 14A0001140361-26-037768
8-K2026-09-281.01 Entry into a Material Definitive Agreement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001140361-26-037767
10-Q2026-08-0510-Q0001005286-26-000033
8-K2026-08-052.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001005286-26-000032
SCHEDULE 13G2026-07-29—0002012383-26-002896
SCHEDULE 13D/A2026-07-02—0000921895-26-001747
8-K2026-07-027.01 Regulation FD Disclosure0001005286-26-000026
SCHEDULE 13D/A2026-07-02—0001193125-26-294951
8-K2026-06-055.02 Departure/Election of Directors or Principal Officers · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits0001005286-26-000023
10-Q2026-05-0610-Q0001005286-26-000020
8-K2026-05-062.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001005286-26-000018
SCHEDULE 13G/A2026-04-27—0002012383-26-001749
DEF 14A2026-04-24DEF 14A0001005286-26-000012
10-KT2026-03-1610-KT0001005286-26-000009
8-K2026-03-162.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001005286-26-000007
8-K2026-03-055.08 Shareholder Nominations0001005286-26-000002